PCR
Simplify VettaFi Private Credit Strategy ETF·ARCA
--
--(--)
--
--(--)
Simplify VettaFi Private Credit Strategy ETF Fundamentals
Assets Under Management
1.95MUSD
Fund Flows (1Y)
--
Dividend Yield (TTM)
4.91%
Discount/Premium to NAV
--
Shares Outstanding
--
Expense Ratio
0.76%
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | -4.73% | -13.56% | -13.39% | -21.02% | -21.02% | -21.02% |
NAV Total Return | -2.80% | -11.12% | -11.99% | — | — | — |
Ratings
Aime Ratings
Add ETF
Add ETF
Add ETF
No data is currently available
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Top 10 Holdings
Symbol
Ratio
VettaFi Private Credit Index
100.14%
B 6/23/26 Govt
76.04%
UBSMQTHTFDFND1M+25 1
31.20%
UBSMPDLTFDFND1M-05 1
18.09%
B 3/31/26 Govt
17.38%
GBDC
Golub Capital BDC
5.39%
ARCC
Ares Capital
5.27%
BXSL
Blackstone Secured
5.19%
OBDC
Blue Owl Capital
5.16%
GOF
Guggenheim Strategic Opportunities Fund
5.14%
Top 10 Weight 269.01%
271 Total Holdings
Is SPY better than PCR?
Dividends
Dividend Payout History
Ex-Div Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2026-02-24 | 2026-02-24 | 2026-02-27 | 0.200 |
| 2026-01-27 | 2026-01-27 | 2026-01-30 | 0.240 |
| 2025-12-23 | 2025-12-23 | 2025-12-31 | 0.230 |
| 2025-11-21 | 2025-11-21 | 2025-11-28 | 0.240 |
| 2025-10-28 | 2025-10-28 | 2025-10-31 | 0.060 |
How Much Does PCR Pay in Dividends?
Premium/Discount Chart
Assets Under Management
Should I buy PCR?
Fund Flows
